KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $1.5 billion.

  • Elevance Health's Current Deferred Revenue fell 99.47% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year decrease of 99.47%. This contributed to the annual value of $1.5 billion for FY2025, which is 99.47% down from last year.
  • As of Q4 2025, Elevance Health's Current Deferred Revenue stood at $1.5 billion, which was down 99.47% from $1.8 billion recorded in Q3 2025.
  • Elevance Health's 5-year Current Deferred Revenue high stood at $4.5 billion for Q2 2023, and its period low was $954.0 million during Q3 2021.
  • In the last 5 years, Elevance Health's Current Deferred Revenue had a median value of $1.5 billion in 2024 and averaged $1.9 billion.
  • Per our database at Business Quant, Elevance Health's Current Deferred Revenue surged by 35911.43% in 2023 and then tumbled by 6677.88% in 2024.
  • Elevance Health's Current Deferred Revenue (Quarter) stood at $1.2 billion in 2021, then dropped by 3.56% to $1.1 billion in 2022, then grew by 26.08% to $1.4 billion in 2023, then rose by 7.56% to $1.5 billion in 2024, then fell by 0.99% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q4 2025, $1.8 billion for Q3 2025, and $1.6 billion during Q2 2025.